Skip to main content
. 2020 Jun 22;10:10078. doi: 10.1038/s41598-020-66821-0

Figure 2.

Figure 2

Compound 018 is a competitive antagonist at α4β1δ receptors and displaces [3H]muscimol binding. (A) Schild plot of 018 at α4β1δ receptors determined in the FMP assay showing a right shift of the GABA concentration-response curve with increasing concentrations of 018 without affecting efficacy. Shown are pooled data from five independent experiments with three technical replicates given as means ± SEM. (B) Schild plot of data displayed in (A) showing a Schild slope of 1.03 indicative of competitive antagonism. (C) Concentration-dependent inhibition of [3H]muscimol binding by 018 and 2027 in rat cortical homogenate, with GABA as reference, showing a competitive profile of the compounds. Data are given as means ± SEM from four independent experiments performed in technical triplicates. The Ki of GABA is 0.049 μM, data from Krall et al.48.